Increased expression of Ca2+/calmodulin-dependent protein kinase IIα during chronic morphine exposure

Neuroscience

Volumn 123, Issue 3, 2004, Pages 769-775

  Liang, D ^a   Li, X ^a   Clark, J D ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Calcium; Gene expression; Morphine; Protein; Spinal cord; Tolerance

Indexed keywords

MESSENGER RNA; MORPHINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN-DEPENDENT PROTEIN KINASE II; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; LONG TERM EXPOSURE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SPINAL CORD; SPINAL CORD DORSAL HORN; TISSUE DISTRIBUTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; UPREGULATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MICE; MICE, INBRED C57BL; MORPHINE; SPINAL CORD; UP-REGULATION;

EID: 0347990407     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.10.007     Document Type: Article

References (38)

1. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci. 15:1995;3328-3341.
2. Asaki C., Usuda N., Nakazawa A., Kametani K., Suzuki T. Localization of translational components at the ultramicroscopic level at postsynaptic sites of the rat brain. Brain Res. 972:2003;168-176.
3. Bhargava H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol Rev. 46:1994;293-324.
4. Bhargava H.N., Cao Y.J. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse. Peptides. 18:1997;1629-1634.
5. Bredt D.S. Endogenous nitric oxide synthesis biological functions and pathophysiology . Free Radic Res. 31:1999;577-596.
6. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
7. Bruggemann I., Schulz S., Wiborny D., Hollt V. Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions. Brain Res Mol Brain Res. 85:2000;239-250.
8. Curtis J., Finkbeiner S. Sending signals from the synapse to the nucleus possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth . J Neurosci Res. 58:1999;88-95.
9. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol. 367:1996;375-402.
10. Fan G.H., Wang L.Z., Qiu H.C., Ma L., Pei G. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol. 56:1999;39-45.
11. Giese K.P., Fedorov N.B., Filipkowski R.K., Silva A.J. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science. 279:1998;870-873.
12. 2+/calmodulin-dependent protein kinases. Annu Rev Biochem. 61:1992;559-601.
13. 2+/calmodulin-dependent protein kinase II. Biochem J. 364:2002;593-611.
14. Iwata S.I., Hewlett G.H., Ferrell S.T., Kantor L., Gnegy M.E. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J Pharmacol Exp Ther. 283:1997;1445-1452.
15. Johnston H.M., Morris B.J. N-methyl-D-aspartate and nitric oxide regulate the expression of calcium/calmodulin-dependent kinase II in the hippocampal dentate gyrus. Brain Res Mol Brain Res. 31:1995;141-150.
16. Kennedy M.B., Bennett M.K., Erondu N.E. Biochemical and immunochemical evidence that the "major postsynaptic density protein" is a subunit of a calmodulin-dependent protein kinase. Proc Natl Acad Sci USA. 80:1983;7357-7361.
17. Koch T., Kroslak T., Mayer P., Raulf E., Hollt V. Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin- dependent protein kinase II in agonist-mediated desensitization. J Neurochem. 69:1997;1767-1770.
18. Li X., Clark J.D. Morphine tolerance and transcription factor expression in mouse spinal cord tissue. Neurosci Lett. 272:1999;79-82.
19. Li X., Clark J.D. Chronic morphine exposure and the expression of heme oxygenase type 2. Brain Res Mol Brain Res. 75:2000;179-184.
20. Li X., Clark J.D. Heme oxygenase inhibitors reduce formalin-induced Fos expression in mouse spinal cord tissue. Neuroscience. 105:2001;949-956.
21. Liang D, Li X, Lighthall G, Clark JD. Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience 121:999-1005.
22. Lisman J., Schulman H., Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci. 3:2002;175-190.
23. Lisman J.E., Zhabotinsky A.M. A model of synaptic memory a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly . Neuron. 31:2001;191-201.
24. 2+/ calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus differential regulation of alpha and beta isoforms . Mol Pharmacol. 55:1999;557-563.
25. Lu L., Zeng S., Liu D., Ceng X. Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett. 291:2000;191-195.
26. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu opioid receptor modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C . J Neurosci. 15:1995;2396-2406.
27. Moriwaki A., Wang J.B., Svingos A., van Bockstaele E., Cheng P., Pickel V., Uhl G.R. mu Opiate receptor immunoreactivity in rat central nervous system. Neurochem Res. 21:1996;1315-1331.
28. 2+/calmodulin- dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation. Proc Natl Acad Sci USA. 93:1996;15451-15456.
29. Omkumar R.V., Kiely M.J., Rosenstein A.J., Min K.T., Kennedy M.B. Identification of a phosphorylation site for calcium/calmodulin-dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 271:1996;31670-31678.
30. Osuka K., Watanabe Y., Usuda N., Nakazawa A., Fukunaga K., Miyamoto E., Takayasu M., Tokuda M., Yoshida J. Phosphorylation of neuronal nitric oxide synthase at Ser847 by CaM-KII in the hippocampus of rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab. 22:2002;1098-1106.
31. Pu L., Bao X., Zou J., Feng D. Individual alumina nanotubes. Angew Chem Int Ed Engl. 40:2001;1490-1493.
32. 2+/calmodulin-dependent protein kinases. Curr Opin Cell Biol. 5:1993;247-253.
33. Soderling T.R., Tan S.E., McGlade-McCulloh E., Yamamoto H., Fukunaga K. Excitatory interactions between glutamate receptors and protein kinases. J Neurobiol. 25:1994;304-311.
34. Terman G.W., Eastman C.L., Chavkin C. Mu opiates inhibit long-term potentiation induction in the spinal cord slice. J Neurophysiol. 85:2001;485-494.
35. (2+)/calmodulin-dependent protein kinase II. Eur J Pharmacol. 465:2003;199-200.
36. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 81:2001;299-343.
37. 2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in non-N-methyl-D-aspartate glutamate receptors. Proc Natl Acad Sci USA. 92:1995;1376-1380.
38. Zhu H., Jang C.G., Ma T., Oh S., Rockhold R.W., Ho I.K. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur J Pharmacol. 365:1999;47-54.